Feider Stephen 4
4 · Beta Bionics, Inc. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Beta Bionics (BBNX) CFO Stephen Feider Sells 6,676 Shares
What Happened
- Stephen Feider, Chief Financial Officer of Beta Bionics (BBNX), sold 6,676 shares on 2026-06-02 in an open-market or private sale. The reported proceeds were approximately $84,165. The sale was disclosed on a Form 4 filed 2026-06-03.
- This was a sale to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs), per the filing footnote — a routine, non-investment-motivated transaction.
Key Details
- Transaction date: 2026-06-02; Form 4 filed: 2026-06-03 (appears timely).
- Shares sold: 6,676; Reported total proceeds: $84,165.
- Prices: weighted average sale price $12.6071; reported range $12.30–$12.93. The filing notes full per-price detail is available upon request.
- Footnotes: F1 — sale made to cover tax withholding on RSU vesting; F2 — weighted average and price range disclosed, full breakdown available on request.
- Shares owned after transaction: not disclosed in the provided filing.
Context
- Sales to cover tax withholding for vested RSUs are common and generally considered routine cash-management transactions rather than a signal of insider sentiment. No options were exercised and no 10% owner or gift activity is involved in this filing.
Insider Transaction Report
Form 4
Feider Stephen
Chief Financial Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-06-02$12.61/sh−6,676$84,165→ 166,053 total
Footnotes (2)
- [F1]The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Signature
/s/ Stephen Feider|2026-06-03